Clinical Trial Update: Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving Positive Airway Pressure (PAP) Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of GZR18 injection in obese adults with obstructive sleep apnea who are receiving PAP therapy; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea

Drugs mentioned

• GZR18 Injection

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Obstructive Sleep Apnea (OSA) | Phase 3 | Status: NOT_YET_RECRUITING